Ex vivo modelling of drug efficacy in a rare metastatic urachal carcinoma.

Published: 15 June 2020| Version 2 | DOI: 10.17632/kc7wmn3rcs.2
Contributor:
Juha Rantala

Description

Supplementary data files for Mäkelä et al. Supplementary data 1. Ex vivo drug screening results. Supplementary data 2. NGS profiling results for MISB18 urachal cancer cell line.

Files

Categories

Drug Screening, Rare Tumor

License